semaglutide sexual function study Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease desire, and a biopsychosocial model for why we don't 'see' it Ozempic 'Potentially' Changes Personality and

These medications are currently being studied for use in conditions like non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, polycystic ovary syndrome (PCOS), and even gastrointestinal disorders and mental health conditions

How do these weight loss medications work

In findings from the STEP TEENS phase 3a trial, adolescents aged 12 to 17 years with obesity or overweight and at least one weight-related coexisting condition were randomly assigned 2:1 to receive semaglutide 2.4 mg (Wegovy, Novo Nordisk) or placebo for 68 weeks

They can also use the data to discover whether you may have other underlying conditions that cause weight gain

Ozempic (Semaglutide) Specific Risks Ozempic, or semaglutide, is used to manage type 2 diabetes